Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A New Classification and Interventional Therapy for Coronary Artery Ectasia

NCT04265989 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.

NCT NCT04265989
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04265989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A New Classification and Interventional Therapy for Coronary Artery Ectasia
Lead sponsor
China National Center for Cardiovascular Diseases
Phase
Not applicable
Overall status
Unknown status
Start date
November 1, 2019
Completion date
November 30, 2021
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery ectasia